Search by property
This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.
List of results
- Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology + (500 µg selenium in the form of sodium selenite (selenase®), orally on radiotherapy days and 300 µg on days without radiotherapy)
- Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology +
- Muecke et al. (2013): Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology-a subgroup analysis of a multicenter, phase III trial + (500 µg selenium in the form of sodium selenite [selenase®), orally on radiotherapy days and 300 µg on days without radiotherapy)
- Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization + (500 µg selenium in the form of sodium selenite [selenase®), orally on radiotherapy days and 300 µg on days without radiotherapy)